Your browser doesn't support javascript.
loading
Evaluation of the Toxicity of Human Dental Pulp-Derived Mesenchymal Stem Cells on Animal Models: An Animal Study.
Thapaswini, Yekula; Phanindra, S; Ramavarapu, Avinash; Kudala, Venkata Raman; Cherukuri, Sai Abhishiktha.
Afiliação
  • Thapaswini Y; Department of Prosthodontics, Sri Sai College of Dental Surgery, Vikarabad, Telangana, India.
  • Nikitha; Department of Prosthodontics, Sri Sai College of Dental Surgery, Vikarabad, Telangana, India.
  • Phanindra S; Department of Prosthodontics, Meghna Institute of Dental Sciences, Nizamabad, Telangana, India.
  • Ramavarapu A; Department of Prosthodontics, Meghna Institute of Dental Sciences, Nizamabad, Telangana, India.
  • Kudala VR; Department of Conservative Dentistry and Endodontics, Tirumala Institute of Dental Sciences and Research Center, Bardipur Village, Dichpally Mandal, Nizamabad, Telangana, India.
  • Cherukuri SA; Dental Surgery, Mamatha Dental College, Khammam, Telangana, India.
J Pharm Bioallied Sci ; 14(Suppl 1): S683-S687, 2022 Jul.
Article em En | MEDLINE | ID: mdl-36110711
Introduction: Dental pulp remains one of the important sources of mesenchymal stem cells for most preclinical and clinical studies. Aim and Objectives: To assess the safety after injecting human dental pulp-derived mesenchymal stem cells by intramucosal and intrabony routes in rabbits for clinical application. Materials and Methods: Animal studies were carried out among 30 New Zealand male white rabbits (3-5 months old), weighing 1.5-2 kgs, which were divided into three groups with 10 animals in each group. Group 1: control group, Group 2: intramucosal route, Group 3: intrabony route. Data were analyzed using Student's t-test, and any P ≤ 0.05 was statistically significant. Results: A total of 30 rabbits were selected for the study, among which significant statistical difference for Packed cell volume (PCV) (P < 0.05), MCHC (P < 0.05), platelet count (P < 0.05), and ESR (p < 0.001) has been reported in the hematological parameters. The results of the present study indicate that the transplantation of hDPSCs by intramucosal and intrabony routes into a rabbit is non-toxic without any detectable side effects or local or systemic rejection. The pre-clinical safety and toxicity of the hDPSCs in various human disease models need to be determined in future studies. Various pre-clinical studies to determine the safety and toxicity of hDPSCs in human disease models have to be done in the future. Conclusion: This study showed that the intramucosal route and intrabony route of administration of stem cells were found to be non-toxic at 10 million per mL concentration. A further evaluation must be done for more definitive results.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Pharm Bioallied Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Pharm Bioallied Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia